Results 91 to 100 of about 14,626,039 (309)

A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors

BMC Cancer, 2020
Background As more states legalize cannabis for medical and recreational use, people increasingly use cannabis to treat medical conditions and associated symptoms.
Susan L. Calcaterra, Andrea N. Burnett-Hartman, J. David Powers, Douglas A. Corley, Carmit M. McMullen, Pamala A. Pawloski, Heather Spencer Feigelson   +6 more
doaj   +1 more source

Frequent cannabis use and the association with seizure burden in drug‐resistant epilepsy

Epilepsia, EarlyView.
Abstract Objective Cannabis use has increased substantially, with modern products characterized by high tetrahydrocannabinol concentrations and variable composition. The relationship between frequent cannabis use and epilepsy outcomes remains uncertain. We examined the association between frequent cannabis use and epilepsy severity, clinical phenotype,
Santiago Philibert‐Rosas, Kaitlin A. Guston, Mariel Kalkach‐Aparicio, Abigail Keller, Sanaa Semia, Theodore Imhoff‐Smith, Cameron J. Brace, Steven E. Haworth, Felipe Branco de Paiva, Dace Almane, Jonathan Williams, Anne Josiah, Bradley Nix, Bruce P. Hermann, Nagesh Adluru, Jana E. Jones, Aaron F. Struck   +16 more
wiley   +1 more source

Association of preconception cannabis use frequency with cannabis use during early pregnancy

BMC Pregnancy and Childbirth
Background Cannabis use during pregnancy is increasingly common and is associated with adverse health outcomes for pregnant individuals and their offspring.
Kelly C. Young-Wolff, Felicia W. Chi, Cynthia I. Campbell, Monique B. Does, Christina N. Wysota, Deborah Ansley, Carley Castellanos, Gwen T. Lapham   +7 more
doaj   +1 more source

Cognitive and Mental Health Predictors of Withdrawal Severity During an Active Attempt to Cut Down Cannabis Use

Frontiers in Psychiatry, 2018
A milestone in cannabis research is the establishment of a clinically relevant cannabis withdrawal syndrome, yet little is known about the underlying mechanisms.
Janna Cousijn, A. C. K. van Duijvenvoorde, A. C. K. van Duijvenvoorde   +2 more
doaj   +1 more source

Changes in effectiveness and safety in patients with Lennox–Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open‐label extension study

Epilepsia Open, EarlyView.
This graphical abstract provides an overview of the content from this post hoc analysis describing the trajectories of fenfluramine effectiveness and safety, along with dose changes over time, in patients with Lennox‐Gastaut syndrome. Abstract In the phase 3 randomized controlled trial (RCT; NCT03355209) of fenfluramine in Lennox–Gastaut syndrome (LGS),
Rima Nabbout, Orrin Devinsky, Lieven Lagae, Ingrid E. Scheffer, Renzo Guerrini, Joseph Sullivan, Antonio Gil‐Nagel, Sameer M. Zuberi, Kate Riney, Patrick Healy, Jayne Abraham, Rebecca Zhang Roper, Mélanie Langlois, Amélie Lothe, Kelly G. Knupp   +14 more
wiley   +1 more source

Clearing the smoke on cannabis: edible cannabis products, cannabis extracts and cannabis topicals. [PDF]

, 2020
Reviews research about edible cannabis products, cannabis extracts and cannabis topicals. Findings of the report include the health and safety risks these types of cannabis products have that are different from the risks associated with dried cannabis ...

core  

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics

Epilepsia Open, EarlyView.
This graphical abstract provides an overview of the content from this post hoc analysis evaluating the efficacy and safety of fenfluramine in patients with Dravet syndrome stratified by age, number of previously attempted antiseizure medications, and SCN1A pathogenic variant status using data pooled from the three pivotal randomized controlled trials ...
Rima Nabbout, Joseph Sullivan, Stéphane Auvin, J. Helen Cross, Orrin Devinsky, Antonio Gil‐Nagel, Renzo Guerrini, Kelly G. Knupp, M. Scott Perry, Rocío Sánchez‐Carpintero, An‐Sofie Schoonjans, Ingrid E. Scheffer, Nicola Specchio, Adam Strzelczyk, James Wheless, Elaine C. Wirrell, Diego Morita, Patrick Healy, Mélanie Langlois, Amélie Lothe, Lieven Lagae   +20 more
wiley   +1 more source

Insight into cannabis use disorder in people with psychotic disorders

BJPsych Open
Background Cannabis use is common in people with psychosis and is associated with poor outcomes. Aims To assess insight into cannabis use disorder, perceptions about how cannabis use influences mental health and the desire to change cannabis use ...
Edward Chesney, Millie Lloyd, Sebastien Brodeur, Arsime Demjaha, Lisa Conlan, Ikram Slimani, Ayşe Doğa Lamper, Ananya Sarma, Will Lawn, Dominic Oliver, Tom P. Freeman, Robin Murray, Marta Di Forti, Amir Englund, John Strang, Philip McGuire   +15 more
doaj   +1 more source

Medical use of cannabis and cannabinoids: questions and answers for policymaking. [PDF]

, 2018
The EMCDDA exists to facilitate a more evidence-informed understanding of issues that are important for developing better drug-related policies and actions across Europe.

core  

Research progress on the role of inflammatory mediators in the pathogenesis of epilepsy

Ibrain, Volume 11, Issue 1, Page 44-58, Spring 2025.
In the central nervous system, activated immune cells lead to the overproduction of inflammatory mediators through the corresponding signal pathway. Under the stimulation of inflammatory factors, neuroinflammation ultimately occurs. Overexpression of inflammatory mediators and activated immunocytes plays an important role in the emergence and ...
Yue Yu, Fei‐Ji Sun
wiley   +1 more source